Development and optimization of magnetite-dextran nanoparticles for lymphoscintigraphy by intravenous injection;MISE AU POINT DE NANOPARTICULES DE MAGNETITE-DEXTRAN DESTINEES A LA LYMPHOSCINTIGRAPHIE PAR VOIE INTRAVEINEUSE

Medecine Nucleaire

Volumn 20, Issue 1, 1996, Pages 6-16

  De Marco, G ^a   Hindre F ^a   Le Jeune, J J ^a   Pouliquen, D ^a   Denizot, B ^a   Jallet, P ^a  

^a Universite d'Angers   (France)

Author keywords

111In labelled nanoparticles; 99mTc labelled nanoparticles; lymphoscintigraphy; radiopharmaceutical; rat

Indexed keywords

DEXTRAN; INDIUM 111; IRON 59; NANOPARTICLE; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ARTICLE; DRUG DISTRIBUTION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOSCINTIGRAPHY; MALE; NONHUMAN; RAT;

ANIMALIA;

EID: 0030048842     PISSN: 09281258     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. De Jager R, Abdel-Nabi H, Serafini A, Pecking A, Klein JL, Hanna MG (1993) Current Status of cancer immunodetection with radiolabeled human monoclonal antibodies. Semin Nucl Med 23, 2, 165-179
2. Perin F, Pittet JC, Hoffschir D, Binz H, Le Pape A (1993) Scintigraphic potentials of J001X acylated poly-galactoside for imaging inflammatory lesions in pigs. Nucl Med Biol 20, 963-971
3. Dooms GC, Hricak H (1986) Radiologic imaging modalities, including resonance, for evaluating lymph nodes. Medical Progress. West J Med 144, 49-57
4. Baulieu F, Baulieu JL, Mesny J, Ducouret N, Benhamou AC, Barsotti J, Itti R (1987) Visualization of the thoracic duct by lymphoscintigraphy. Eur J Nucl Med 13, 264-265
5. 99mTc in the evaluation of the removal capacity of the reticuloendothelial system. Eur J Nucl Med 13, 254-257
6. Taupitz M, Hamm B, Mohren P, Wagner S, Wolf KJ (1989) Magnetites as contrast agent in MR lymphography: an experimental study in rabbits. European Society for Magnetic Resonance in Medicine and Biology, Amsterdam
7. Weissleder R, Elizondo G, Wittenberg J (1990) Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR Imaging. Radiology 175, 489-493
8. Weissleder R, Elizondo G, Wittenberg J (1990) Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 175, 494-498
9. Lee AS, Weissleder R, Brady TJ, Wittenberg J (1991) Lymph nodes: microstructural anatomy at MR imaging. Radiology 178, 519-522
10. Guimaraes R, Clement O, Bittoun J, Carnot F, Frija G (1994) MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis for contrast enhancement. Am J Radiol 162, 201-207
11. Harika L, Weissleder R, Poss K, Zimmer C, Papisov M, Brady T (1995) MR lymphography with a lymphotropic T1-type MR contrast agent: Gd-DTPA-PGM. Magn Reson Med 33, 88-92
12. Yoshimi A, McLachlan S, Moms M, Saxton R, Lufkin Robert B (1994) Dextran-coated superparamagnetic iron oxide, an MR contrast agent for assessing lymph nodes in the head and neck. AJNR 15, 87-94
13. Yoshimi A, Keith Blackwell, Lufkin Robert B (1994) Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer. Radiology 192, 709-715
14. Chouly C, Pouliquen D, de Marco G, Lucet I, Le Jeune JJ, Jallet P (1992) Development of neutral superparamagnetic iron oxide nanoparticles (MD) as contrast agent for MRI of liver, spleen, and MR lymphography. Soc Magn Res Med, Berlin, 865
15. Molday RS, MacKenzie D (1982) Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. J Immunol Methods 52, 353-367
16. Pouliquen D, Le Jeune JJ, Perdrisot R, Ermias A, Jallet P (1991) Iron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolism. Magn Reson Imaging 9, 275-283
17. Perdrisot R (1989) Synthèse, marquage et évaluation de vecteurs macromoléculaires et microcapsulaires utilisables en imagerie médicale. Thèse de sciences, université du Maine
18. Pouliquen D, Perdrisot R, Ermias A, Akoka S, Jallet P, Le Jeune JJ (1989) Superparamagnetic iron oxyde nanoparticles as a liver MRI contrast agent: contribution of microencapsulation to improved biodistribution. Magn Reson Imaging 7, 619-627
19. Muller RH (1989) Colloidal carriers for controlled drug delivery: modification, characterization and in vivo distribution. PhD thesis, University of Kiel, West Germany
20. Dubois M, Gilles KA, Hamilton JK (1956) Colorimetric method for determination of sugars and related substances. Anal Chem 28, 350-356
21. Tissot M, Beauvallet M, Giroud JP (1978) Polyarthrite à adjuvant de Freund chez le rat « inbred » Lewis - catécholamines et 5-hydroxytryptamine. Cerveau et surrénales. J Pharmacol (Paris) 9, 193-203
22. Antoine E, Pauwels P, Verelle P, Lascaux V, Poupon MF (1988) In vivo emergence of a highly metastatic tumour cell line from a rat rhabdomyosarcoma after treatment with an alkylating agent. Br J Cancer 57, 469-474
23. Gabe M (1985) Techniques histologiques. Masson, Paris
24. Pottu-Boumendil J (1989) Techniques en microscopie électronique, principes et méthodes de préparation. Éditions Inserm, Paris
25. Makoto Tanaka, Yasuyuki Takeda, Suguru Takeo (1993) Serum antibody production by oral immunization with dextran B512. Immunol Methods 159, 245-251
26. Okon E, Pouliquen D, Okon P, Kovaleva ZV, Stepanova TP, Lavit SG, Kudryavtsev BN, Jallet P (1994) Biodegradation of magnetite dextran nanoparticles in the rat: a histologic and biophysical study. Lab Invest 71, 895-903
27. 111In-labelled magnetite. Appl Radiat Isot 40, 751-757